MPox Vaccinia Trials Market Size and Forecast The global market related to Mpox vaccines and treatments is highly dynamic, driven by the recent global outbreak and the necessity for robust public health…
COVID Adintrevimab Market: Size, Forecast, Drivers, and Key Trends
Adintrevimab Market Size and Forecast Adintrevimab’s market size is defined by its role as a prophylactic and therapeutic monoclonal antibody for COVID-19, contingent on the drug’s regulatory status and the current pandemic…
RSV Clesrovimab Phase Market: Size, Forecast, Drivers, and Key Trends
Clesrovimab Phase Market Size and Forecast Clesrovimab (MK-1654) represents a next-generation monoclonal antibody being developed for the prevention of respiratory syncytial virus (RSV) infection in infants. As a preventative product, its market…
Flu Xofluza Peds Market: Size, Forecast, Drivers, and Key Trends
Flu Xofluza Pediatric Market Size and Forecast The pediatric influenza treatment market, which includes antivirals like Xofluza, was valued at approximately USD 929.76 million in 2024. Xofluza (baloxavir marboxil) is a relatively…
Autism Arbaclofen Market: Size, Forecast, Drivers, and Key Trends
Autism Arbaclofen Market Size and Forecast The market for Arbaclofen, specifically targeting Autism Spectrum Disorder (ASD), is characterized by its high unmet need for effective treatments addressing core symptoms like social withdrawal….
HD RG6042 Market: Size, Forecast, Drivers, and Key Trends
HD RG6042 Market Size and Forecast The market potential for HD RG6042, now known as Tominersen, is closely tied to the global Huntington’s disease (HD) therapeutics market, which represents a significant unmet…
PD ND0612 Market: Size, Forecast, Drivers, and Key Trends
PD ND0612 Market Size and Forecast The market for PD ND0612 is focused on advanced stage Parkinson’s disease (PD) patients experiencing “off” periods and motor fluctuations, who require continuous drug delivery. While…
AD Aducanumab Halt Market: Size, Forecast, Drivers, and Key Trends
AD Aducanumab Halt Market Size and Forecast The Aducanumab (Aduhelm) market, despite its initial Accelerated Approval for Alzheimer’s disease (AD), faced significant commercial limitations and controversy. Biogen announced in January 2024 that…
PTSD Ganaxolone Market: Size, Forecast, Drivers, and Key Trends
PTSD Ganaxolone Market Size and Forecast The Post-Traumatic Stress Disorder (PTSD) treatment market is substantial, valued at around USD 2.28-2.37 billion in 2024/2025, with projections indicating growth up to USD 3.42 billion…
OCD Tranylcypromine Market: Size, Forecast, Drivers, and Key Trends
Tranylcypromine for OCD: Market Size and Forecast The market specifically for Tranylcypromine in treating Obsessive-Compulsive Disorder (OCD) is considered a niche segment within the broader OCD drug landscape. While Serotonergic Reuptake Inhibitors…